NCT02864446

Brief Summary

Urinary intestinal fatty acid binding protein (i-FABP), a marker of intestinal mucosal cell damage, has recently been proposed as a clinically useful measure in the early detection of necrotizing enterocolitis (NEC). However, there are no data on urinary i-FABP in meconium obstruction of prematurity (MOP). This study aimed to evaluate urinary i-FABP in MOP patient as a marker for early detection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 12, 2016

Completed
Last Updated

August 12, 2016

Status Verified

August 1, 2016

Enrollment Period

2.9 years

First QC Date

August 2, 2016

Last Update Submit

August 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of i-FABP level between the meconium obstruction group and the normal feeding advance group

    within 48 hours after birth

Other Outcomes (5)

  • Comparison of i-FABP level between breast milk feeding and formular feeding in the normal feeding advance group

    through study completion (an average of 1 month)

  • Comparison of i-FABP level between preterm infants with small for gestational age and without small for gestational age in the normal feeding advance group

    within 48 hours after birth

  • Comparision of i-FABP level between preterm infants with chorioamnionitis and without chorioamnionitis in the normal feeding advance group

    within 48 hours after birth

  • +2 more other outcomes

Eligibility Criteria

AgeUp to 36 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants weighing \<1,250g who were admitted in neonatal intensive care unit at Seoul National University Children's Hospital * Initial urine samples are collected at the time of 12, 24, 48 hours (+/- 6 hours) after birth. * Further urine samples are collected every 48 hours when the enteral feeding starts. (till the amount of feeding reaches to 40mL/kg/day)

You may qualify if:

  • preterm infants weighing \<1,250g

You may not qualify if:

  • major congenital anomalies
  • perinatal asphyxia (cord pH \<7.0)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

urine

MeSH Terms

Conditions

Meconium Ileus

Condition Hierarchy (Ancestors)

Intestinal ObstructionIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 2, 2016

First Posted

August 12, 2016

Study Start

October 1, 2012

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

August 12, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

Locations